ReviewInfection and immunity2008
Two-component signal transduction proteins as potential drug targets in medically important fungi.
Review in Infection and immunity, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed.
- Article
- Backbone and side‑chainBiomolecular NMR assignments · 2025Article
- Polypeptides TargetingJournal of fungi (Basel, Switzerland) · 2023Article
- Proteomics of Two Thermotolerant Isolates ofJournal of fungi (Basel, Switzerland) · 2021Article
- Candida albicans CHK1 gene from two-component system is essential for its pathogenicity in oral candidiasis.Applied microbiology and biotechnology · 2021Article
- Methanolic Extract of the HerbPharmaceuticals (Basel, Switzerland) · 2020Article
- Virulence and biofilms as promising targets in developing antipathogenic drugs against candidiasis.Future science OA · 2020Review
- Adaptation to macrophage killing byFuture science OA · 2017Review
- The yeasts phosphorelay systems: a comparative view.World journal of microbiology & biotechnology · 2017Review
- Regulation of Candida albicans Interaction with Macrophages through the Activation of HOG Pathway by Genistein.Molecules (Basel, Switzerland) · 2016Article
- Potential Targets for Antifungal Drug Discovery Based on Growth and Virulence in Candida albicans.Antimicrobial agents and chemotherapy · 2015Review
- Hitting the caspofungin salvage pathway of human-pathogenic fungi with the novel lasso peptide humidimycin (MDN-0010).Antimicrobial agents and chemotherapy · 2015Article
- Two-component histidine phosphotransfer protein Ypd1 is not essential for viability in Candida albicans.Eukaryotic cell · 2014Article
- Molecular mechanisms of action of herbal antifungal alkaloid berberine, in Candida albicans.PloS one · 2014Article
- Deletion of the HAMP domains from the histidine kinase CaNik1p of Candida albicans or treatment with fungicides activates the MAP kinase Hog1p in S. cerevisiae transformants.BMC microbiology · 2013Article
- Mitochondrial two-component signaling systems in Candida albicans.Eukaryotic cell · 2013Article
- Article
- Analysis of bacterial biofilms using NMR-based metabolomics.Future medicinal chemistry · 2012Review
- Candida albicans SRR1, a putative two-component response regulator gene, is required for stress adaptation, morphogenesis, and virulence.Eukaryotic cell · 2011Article
- Oxidative stress survival in a clinical Saccharomyces cerevisiae isolate is influenced by a major quantitative trait nucleotide.Genetics · 2011Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.